Kurt R. Auger - Concepedia

Author

Kurt R. Auger

GlaxoSmithKline (United States)

Also Known As

Kurt Auger, Kurt R Auger, Kurt R. Auger, Kurt R. Auger

Publications

8.3K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)South College GlaxoSmithKline (United Kingdom)Dana-Farber Cancer Institute Harvard University

About

Kurt R. Auger is an author at GlaxoSmithKline (United States) specializing in medicine, cell biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	4K
2	Natural Sciences	8	8	745
3	Biochemistry	8	8	584
4	Engineering	1	1	91
5	Biomedical Engineering	1	1	91

Kurt R. Auger

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia Mark A. Dawson, Rab K. Prinjha, Antje Dittmann, Nature Hematological MalignancyChromatinBet RecruitmentMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2011	1.5K
PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells Kurt R. Auger, Leslie A. Serunian, Stephen P. Soltoff, Cell Intact CellsSignal TransductionDevelopmental BiologySignaling PathwayMedicine	1989	924
Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase Hwai Wen Chang, Masahiro Aoki, David Fruman, Science	1997	415
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin Steven D. Knight, Nicholas D. Adams, Joelle L. Burgess, ACS Medicinal Chemistry Letters Highly Potent InhibitorTumor BiologyMammalian TargetSignaling PathwayCancer Cell Biology	2010	367
BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models Anastasia Wyce, Gopinath Ganji, Kimberly N. Smitheman, PLoS ONE Mycn Copy NumberBet Family ProteinsCell RegulationOncogenic AgentMedicine	2013	203
A Tightly Associated Serine/Threonine Protein Kinase Regulates Phosphoinositide 3-Kinase Activity Christopher L. Carpenter, Kurt R. Auger, Brian Duckworth, Molecular and Cellular Biology Molecular RegulationMolecular BiologyPathologyImmunologic MechanismCellular Physiology	1993	194
Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization Zhihong Lai, Katherine V. Ferry, Melody Diamond, Journal of Biological Chemistry	2001	167
Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation Leslie A. Serunian, Kurt R. Auger, Lewis C. Cantley Methods in enzymology on CD-ROM/Methods in enzymology ThrombopoiesisThrombosisGrowth HormoneBlood PlateletMedicine	1991	150
Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide Susan M. Domchek, Kurt R. Auger, Swati Chatterjee, Biochemistry	1992	139
Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase Jeffrey D. Carson, Glenn Van Aller, Ruth Lehr, Biochemical Journal Signal TransductionSignaling PathwayBiochemistryClass Ia Pi3ksNatural Sciences	2007	118

Page 1